| |
We at Sunzen Group believe that R&D is the most crucial activity for the Group, as it forms the foundation of Sunzen’s continuous innovation. The Group typically allocates 1% to 3% of annual revenue for R&D initiatives.
Our R&D efforts are guided by the following policies:
| a) |
To introduce and develop innovative “green” animal health products that are progressive and have a large untapped market potential. These products are based on natural substances that are safe for humans, animals and the environment. |
| b) |
To maximize the value of our existing products by enhancing the features, efficacy, species applicability and/or discovering new uses for it. |
| c) |
To conduct our research activities in an ethical manner in accordance with standard scientific methods and practices. |
| d) |
To continuously invest in human capital and R&D assets as they are the foundation of our long-term business success. |
|
